California Clinical and Translational Pain Research Consortium

NIH RePORTER · NIH · U24 · $101,192 · view on reporter.nih.gov ↗

Abstract

Abstract The complex nature of the subjective experience of pain and lack of effective treatments for chronic pain has led to the ongoing “opioid epidemic” (CITE). Converging lines of evidence suggest that the ongoing chronic pain and opioid crisis will be addressed by discovering novel, multimodal therapeutic approaches employing a solid research network to promote and conduct high quality, efficient clinical trials. In this proposal, we outline a Hub-spoke complex (California Clinical and Translational Pain Research Consortium (CCTPRC)) consisting of four University of California academic medical centers. These centers have considerable experience in pain management clinical trials, phenotyping and biomarker validation. Our network will leverage solid existing CTSA resources to make clinical trial execution efficient and rapid. The Hub will be located at the University of California San Diego with spokes located on the other three campuses to provide maximum flexibility, ready to accommodate studies in a variety of pain conditions and provide successful recruitment and high-quality data collection.

Key facts

NIH application ID
11081925
Project number
4U24NS115714-02
Recipient
UNIVERSITY OF CALIFORNIA, SAN DIEGO
Principal Investigator
MARK S WALLACE
Activity code
U24
Funding institute
NIH
Fiscal year
2024
Award amount
$101,192
Award type
4N
Project period
2019-09-30 → 2025-08-31